Data Sheet 1_Evaluation of clinical, analytical, and genotyping performance of Hex L1 real-time PCR coupled with high-resolution melting curve analysis for fowl adenovirus outbreak... Tekijä Amina Kardoudi (22686524)

Aiheet:

Image 1_Evaluation of clinical, analytical, and genotyping performance of Hex L1 real-time PCR coupled with high-resolution melting curve analysis for fowl adenovirus outbreak inve... Tekijä Amina Kardoudi (22686524)

Aiheet:

Image 2_Evaluation of clinical, analytical, and genotyping performance of Hex L1 real-time PCR coupled with high-resolution melting curve analysis for fowl adenovirus outbreak inve... Tekijä Amina Kardoudi (22686524)

Aiheet:

Table 1_Evaluation of clinical, analytical, and genotyping performance of Hex L1 real-time PCR coupled with high-resolution melting curve analysis for fowl adenovirus outbreak inve... Tekijä Amina Kardoudi (22686524)

Aiheet:

Airborne Spread of SARS-CoV-2 Between Rooms in a Sealed, Mechanically Ventilated Ward: Evidence from a Hospital Outbreak Investigation Tekijä Yo Ishigaki (11052900)

Aiheet:

Multivariate analysis between DENV and CHIKV seroconversion and selected risk factors. Tekijä Bethel Alebel Bayrau (22676588)

Aiheet:

Seroprevalence of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022. Tekijä Bethel Alebel Bayrau (22676588)

Aiheet:

Descriptive statistics and demographics of study participants, Ukunda and Kisumu sites, Kenya, Dec 2019–Feb 2022. Tekijä Bethel Alebel Bayrau (22676588)

Aiheet:

DENV and CHIKV IgG serology and RT-PCR test results among overall study population and individual study sites Ukunda and Kisumu, Kenya, Dec 2019–Feb 2022. Tekijä Bethel Alebel Bayrau (22676588)

Aiheet:

Univariate analysis between DENV and CHIKV seropositivity and selected risk factors. Tekijä Bethel Alebel Bayrau (22676588)

Aiheet:

Seroconversion of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022. Tekijä Bethel Alebel Bayrau (22676588)

Aiheet:

Kaplan Meier survival curves for new CHIKV seropositivity during the 2- year study period from Dec 2019 – Feb 2022. Tekijä Bethel Alebel Bayrau (22676588)

Aiheet:

Kaplan Meier survival curves for new DENV seropositivity during the 2-year study period from Dec 2019 – Feb 2022.. Tekijä Bethel Alebel Bayrau (22676588)

Aiheet:

Multivariate analysis between DENV and CHIKV seropositivity and selected risk factors. Tekijä Bethel Alebel Bayrau (22676588)

Aiheet:

Univariate analysis between DENV and CHIKV seroconversion and selected risk factors. Tekijä Bethel Alebel Bayrau (22676588)

Aiheet:

Distribution of DENV and CHIKV seroprevalence by age group of participants in the study. Tekijä Bethel Alebel Bayrau (22676588)

Aiheet: